ANTIVERT TAB DIN 00158127
Health Canada record
| Active ingredient(s) | MECLIZINE HYDROCHLORIDE 12.5 MG; NICOTINIC ACID 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | R06AE55 MECLOZINE, COMBINATIONS |
| Original market date | 31-Dec-1956 |
| Current status date | 24-Jan-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MECLIZINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02368838 | BONAMINE | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Tablet (Immediate-Release) | MECLIZINE HYDROCHLORIDE 25 MG | Cancelled Pre Market |
| 00220442 | BONAMINE TAB 25MG CHEWABLE | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Tablet (Chewable) | MECLIZINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
International API supply for MECLIZINE HYDROCHLORIDE
10 active FDA Drug Master Files.
Request a quote for ANTIVERT TAB